Oncology solutions for
in vitro diagnostic use

pink dots icon

Unlock the power of precision oncology.

With the advanced analytical performance of the SOPHiA DDM™ Platform, our CE-marked in vitro diagnostic (IVD) solutions transform raw next-generation sequencing (NGS) data into actionable insights.

As genomic analysis becomes increasingly available in both clinical and research settings, clinicians are faced with the complex task of translating raw data into precision medicine approaches. Our CE-IVD-marked genomic applications offer end-to-end workflows that support accurate data analysis and reveal actionable insights, informing data-driven decisions that improve the quality of patient care.

Powered by advanced analytical capabilities, our CE-IVD solutions help clinicians and researchers pinpoint causative variants in tumor samples. The SOPHiA DDM™ Platform supports delivery of relevant data insights via two user-friendly modes:

  • The CE-IVD compliant web-based SOPHiA DDM™ Platform provides an intuitive workspace to analyze and report NGS data for our CE-IVD solutions.
  • The SOPHiA DDM™ Platform desktop access mode offers an additional clinical decision support (CDS) component that allows further visualization, interpretation, and reporting of NGS data.
SOPHiA Myeloid Solution Screenshot

End-to-end workflow for our CE-IVD solutions.
CDS, clinical decision support; IVD, in vitro diagnostic; NGS, next-generation sequencing.
*CDS tools and reports will vary depending on product.

pink dots icon

Explore how our CE-IVD solutions empower
clinical decision-making

SOPHiA DDM Dx Homologous Recombination Deficiency (HRD) Solution

Support accurate detection of HRD status in ovarian cancer samples with SOPHiA DDM Dx HRD Solution – a deep learning-powered diagnostic application leveraging low-pass whole genome sequencing to identify patterns of genomic instability.

SOPHiA DDM Dx RNAtarget Oncology Solution (ROS)

Expect more from your fusion detection workflow with SOPHiA DDM Dx ROS – a diagnostic application providing advanced analytical performance of RNA-based novel fusion detection in small biopsy samples.

SOPHiA DDM Dx Myeloid Solution (MYS)

Expand the scope of myeloid neoplasm management with SOPHiA DDM Dx MYS – a diagnostic application providing advanced analytical performance for the detection of single nucleotide variants (SNVs), insertions and deletions (Indels) and FLT3-internal tandem duplications in blood samples.

SOPHiA DDM Dx Hereditary Cancer Solution (HCS)

Confidently assess genomic variants linked to major hereditary cancer syndromes with SOPHiA DDM Dx HCS – a diagnostic application using capture-based target enrichment and tailored analytics to accurately detect SNVs and Indels.

SOPHiA DDM Dx Solid Tumor Solution (STS)

Benefit from advanced molecular profiling of a broad range of solid tumors with SOPHiA DDM Dx STS – a streamlined and efficient diagnostic application combining powerful analytics with capture-based target enrichment for high-quality and confident SNV and Indel detection.

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.